RNO 0.00% 4.0¢ rhinomed limited

MUTE is truly disruptive, page-3

  1. 755 Posts.
    Shift,

    You say sensational trial results for Mute. What were the trial that were conducted and by whom.
    If the trials only took a short period of time and not conducted by ENT specialists then there has not been proper trials conducted. only in house and not medically proven.
    .
    The company has stated that it is not for sleep apnea, all sleep apnea sufferers get medical treatment from ENT specialists and use products that are trialled under strict conditions to give them the required approval for medical devices.

    Are the trials from Monash being conducted under the school of medicine or the engineering section.

    There are products out in the market place recommended by the medical profession that assist non sleep apnea snorers one of which is Slumber Guard reasonably priced with a six month guarantee and being recommended by physicians.

    As for the drug delivery version I ask the question how can it be worth hundreds of millions of dollars starting mid next year. These types of devices take years to qualify through the official regulatory requirements not 12-18 months. I agree that it may be a good product in the long term if it passes testing, but not in the short term will it turn RNO into another resmed.

    IMO DYOR
 
watchlist Created with Sketch. Add RNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.